TJHA
HQL

Thomas J. Herzfeld Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180K Buy
+11,076
New +$185K 0.06% 72
2025
Q4 		– Sell
-116,937
Closed -$1.81M – 113
2025
Q3 		$1.81M Buy
+116,937
New +$1.6M 0.62% 45
2024
Q1 		– Sell
-882
Closed -$11.9K – 155
2023
Q4 		$11.9K Sell
882
-116,022
-99% -$1.43M ﹤0.01% 123
2023
Q3 		$1.46M Buy
116,904
+13,414
+13% +$176K 0.56% 50
2023
Q2 		$1.4M Buy
+103,490
New +$1.43M 0.56% 52
2019
Q2 		– Sell
-39,562
Closed -$678K – 283
2019
Q1 		$678K Buy
39,562
+16
+0% +$276 0.25% 90
2018
Q4 		$598K Buy
39,546
+36,873
+1,379% +$649K 0.24% 84
2018
Q3 		$55K Hold
2,673
– – 0.02% 160
2018
Q2 		$50K Buy
+2,673
New +$50.3K 0.02% 178
2017
Q4 		– Sell
-69
Closed -$1K – 324
2017
Q3 		$1K Buy
69
+1
+1% +$21 ﹤0.01% 286
2017
Q2 		$1K Buy
68
+1
+1% +$20 ﹤0.01% 283
2017
Q1 		$1K Buy
67
+1
+2% +$19 ﹤0.01% 294
2016
Q4 		$1K Buy
66
+1
+2% +$18 ﹤0.01% 304
2016
Q3 		$1K Buy
65
+2
+3% +$38 ﹤0.01% 293
2016
Q2 		$1K Buy
63
+1
+2% +$18 ﹤0.01% 306
2016
Q1 		$1K Buy
62
+1
+2% +$18 ﹤0.01% 332
2015
Q4 		$1K Buy
61
+1
+2% +$25 ﹤0.01% 321
2015
Q3 		$1K Buy
+60
New +$1.68K ﹤0.01% 322
2015
Q2 		– Sell
-58
Closed -$2K – 312
2015
Q1 		$2K Sell
58
-332
-85% -$9.05K ﹤0.01% 292
2014
Q4 		$10K Sell
390
-1,535
-80% -$36.8K 0.01% 234
2014
Q3 		$43K Buy
1,925
+61
+3% +$1.32K 0.02% 206
2014
Q2 		$39K Sell
1,864
-4,736
-72% -$99.4K 0.02% 211
2014
Q1 		$144K Buy
+6,600
New +$147K 0.08% 161

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Thomas J. Herzfeld Advisors's HQL Position: Q1 2026 in Review

Thomas J. Herzfeld Advisors opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 11,076 shares worth $180K. The stake represents 0.06% of the portfolio and ranks #72 among its holdings. This is a return to the name: Thomas J. Herzfeld Advisors previously reported a position in HQL as recently as Q3 2025.

Thomas J. Herzfeld Advisors first reported a position in HQL in Q1 2014 and has held it in 23 quarters since. The position peaked at $1.81M in Q3 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Thomas J. Herzfeld Advisors held 11,076 shares of abrdn Life Sciences Investors worth $180K as of Q1 2026.
  • abrdn Life Sciences Investors was a new Thomas J. Herzfeld Advisors position in Q1 2026.
  • abrdn Life Sciences Investors made up 0.06% of Thomas J. Herzfeld Advisors's portfolio in Q1 2026, its #72 holding.
  • Thomas J. Herzfeld Advisors first reported a position in abrdn Life Sciences Investors in Q1 2014 and has held it in 23 quarters since.
  • Thomas J. Herzfeld Advisors's abrdn Life Sciences Investors position peaked at $1.81M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q1 2026, filed 12 May 2026.